Table 1.
CD4-chimera | No. of experiments | No. of myotubes counted | % myotubes with clusters |
---|---|---|---|
CD4 | 5 | 80 | 1 |
CD4− | |||
α loop | 5 | 88 | 0 |
β loop | 6 | 94 | 73 |
γ loop | 3 | 57 | 0 |
δ loop | 5 | 63 | 3 |
ε loop | 5 | 75 | 0 |
β333–406 | 6 | 117 | 74 |
β407–469 | 5 | 84 | 2 |
β333–406/ε | 6 | 111 | 77 |
β370–406 | 3 | 60 | 45 |
β loop Y390F | 6 | 100 | 1 |
β333–406 Y390F | 3 | 57 | 2 |
β333–406/ε Y390F | 3 | 53 | 0 |
β370–406 Y390F | 3 | 60 | 3 |
CD4ct− | |||
β382–401 | 3 | 60 | 88 |
β382–401 Y390F | 3 | 60 | 15 |
β385–396 | 3 | 60 | 5 |
δ385–404 | 3 | 60 | 22 |
CD4-chimera-positive myotubes were identified in random fields and scored for the presence or absence of CD4 clusters that colocalized with AChR clusters. Agrin induced robust clustering of CD4-β loop chimeras encompassing amino acids 382–401, with 45–88% of the expressing myotubes having clusters. Mutation of Y390 abolished clustering of these constructs, and all other CD4-loops showed background or weak colocalization with AChR clusters.